| 标题 |
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease |
| 网址 | |
| DOI |
10.1182/blood-2008-05-155846
doi
|
| 其它 |
期刊:Blood 作者:Norihiro Nishimoto; Kimio Terao; Toru Mima; Hideko Nakahara; Nobuhiro Takagi; et al 出版日期:2008-09-11 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)